Developer docs
API playgroundTry for free, no card

Search company profiles

SERMO

Full company profile

uuid0005bq9

Namestring
SERMO
Legal namestring
Sermo, Inc.
Websiteurl
sermo.com
Company typeenum
Private
Founded yearint
2005
Descriptiontext

Sermo is a physician-first social engagement platform that connects over 1 million triple-verified physicians and healthcare professionals across 150+ countries. Founded in 2005 and headquartered in New York, the company operates a closed, credentialed community where physicians participate in peer discussions, post challenging patient cases (2M+ peer insights shared annually), rate drugs in the world's largest physician drug ratings database (1.2M+ ratings), and complete paid market research surveys (with over $25M distributed to medical professionals last year). The platform extends to dedicated sub-communities for Advanced Practice Providers and Pharmacists, and produces the recurring Sermo Barometer HCP sentiment study series, now in its 45th edition.

The underlying technology combines social networking infrastructure, a proprietary triple-verification credential system for physician onboarding, the Drug Ratings™ branded database, mobile applications (app.sermo.com), and AI-powered analytics for personalized marketing and engagement insights. The platform's core technical differentiator is its scale: 1.5M+ verified members producing a continuous stream of structured and unstructured clinical signal that competitors cannot easily replicate.

Sermo's business model is a two-sided platform play. Physicians access the network free of charge and earn supplemental income through paid surveys, while pharmaceutical companies, medical device firms, and biotech firms pay for access through multiple revenue streams including RealTime surveys, sponsored content, Sermo Conversations, Sermo Promo, and Sermo Ratings. The October 2025 launch of Engagement Manager added on-demand self-serve advertising, and the 2021 acquisition of Australia's Minter Group expanded Asia-Pacific reach with 50,000+ additional healthcare professionals. The company is privately held, has received approximately $101M in disclosed funding across multiple rounds (most recently Series 4 from ABRY Partners in 2019), and is led by CEO Peter Kirk.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
501–1,000
akta.pro rankint
HeadquartersNew York, United States
HQ citystring
New York
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
physician social network, healthcare market research, HCP engagement platform, physician drug ratings, medical insights surveys
Industry2 codes
PRIMARYHLAGACAG
Clinical Trial Monitoring Support (On-site/Remote)
SECONDARYHLAGAOAA
Clinical Operations & Monitoring FSP (CRA/CTM/Start-up)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Scientific Staffing & Functional Service Providers (FSP)
NAICS code1 code
  • Web Search Portals, Libraries, Archives, and Other Information Services519
SIC code1 code
  • Services-Health Services8000
Product category
Healthcare Professional Network & Market Research Platform
Social media profiles3 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model2 records
1Pharmaceutical and Healthcare Industry Insights
TypeSubscription Recurring
Description

Sermo provides pharmaceutical companies, medical device firms, and biotech companies with access to physician expertise through sponsored content, engagement sponsorship, RealTime surveys, Sermo Conversations, Sermo Promo, and Sermo Ratings. Organizations underwrite market research and engagement sponsorship opportunities on the platform.

sermo.com
2Market Research Surveys
TypeTransaction Fee
Description

Sermo facilitates paid medical surveys matching physician specialties, earning revenue from pharmaceutical clients who fund the surveys while physicians earn money for their participation. Medical professionals on Sermo earned over $25+ million in compensation last year.

sermo.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure
Pricing details1 tier
1Free membership for physicians with earning opportunities through paid surveys
ModelFreemiumBilling cadencePay-as-you-go
Notes

Physicians can join free and earn supplemental income through paid medical surveys. Medical professionals on Sermo earned over $25+ million last year from survey participation. Specific survey compensation amounts vary by specialty and study.

sermo.com
GTM typeB2B
B2B
Offering typeSoftware
Software
Core offering1 text field

SERMO operates a verified physician-only social networking platform with over 1.5 million healthcare professionals across 150+ countries, providing peer-to-peer medical collaboration, paid medical surveys, and the world's largest physician drug ratings database (1.2M+ ratings). The company monetizes this network by offering pharmaceutical companies, medical device firms, and biotech clients access to physician insights, sponsored engagement, real-time market research surveys, and on-demand advertising via its Engagement Manager platform.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • 83% increase in global unique logins during COVID-19 pandemic
+2 more records
Product overview1 text field

Sermo is a physician-first social engagement platform and healthcare insights company offering a suite of interconnected products: the core Sermo Physician Social Network (a triple-verified social platform for 1M+ doctors), paired with the world's largest Drug Ratings Database (1.2M+ ratings) and a Paid Medical Survey program. The platform facilitates Peer Insights for case consultations (2M+ insights annually) and powers the Sermo Barometer, a recurring HCP sentiment study series now in its 45th edition that generates industry-wide healthcare insights. Additional offerings include the Engagement Manager (on-demand advertising access to verified HCPs), dedicated communities for APPs and Pharmacists, and a mobile application. The platform architecture combines social networking, market research, and real-world evidence generation for pharmaceutical and healthcare industry clients.

Product and service5 records
1Sermo Physician Social Network
CategorySocial networking platform
Description

The primary social networking platform for verified physicians and healthcare professionals, enabling peer-to-peer medical discussions, case consultations, anonymous interactions, and professional networking across 1.5M+ members in 150+ countries.

2Drug Ratings Database
CategoryPhysician drug review database
Description

The world's largest database of physician drug reviews containing over 1.2 million ratings, enabling physicians to share and access treatment reviews to improve patient care decisions globally.

3Paid Medical Surveys
CategoryMarket research surveys
Description

Market research surveys matching physician specialties that enable medical professionals to earn supplemental income by sharing clinical expertise through paid participation in healthcare research studies funded by pharma clients.

4Sermo Barometer
CategoryHCP sentiment research
Description

A recurring HCP sentiment study series (45th edition) surveying thousands of global healthcare professionals on clinical trends, treatment patterns, industry challenges, and emerging therapies to generate actionable healthcare insights for pharmaceutical and industry clients.

5Engagement Manager
CategoryOn-demand advertising platform
Description

An on-demand advertising platform enabling pharmaceutical companies and healthcare advertisers to access and target SERMO's community of 1M+ triple-verified healthcare professionals with sponsored content and advertising.

Scale indicator7 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
1Minter Group
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2021-06-15
Description

Acquired Australia-based market research leader Minter Group on June 15, 2021. The acquisition expanded Sermo's research panel to include over 50,000 Asia-Pacific healthcare professionals, strengthening connections between the pharmaceutical industry and healthcare providers in emerging markets, particularly Asia-Pacific.

pharmiweb.com
Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Veeva Systems provides cloud-based software for life sciences companies, including CRM, data, and commercial engagement tools used by pharma sales and marketing teams. It overlaps with Sermo's pharma customer base and HCP engagement use cases, but as a broader enterprise platform rather than a physician community.

TypeBroad incumbent
Description

Definitive Healthcare provides commercial intelligence and analytics on healthcare providers, including physicians, for life sciences and healthcare organizations. It is broadly comparable to Sermo as a healthcare commercial intelligence/data provider serving pharma clients.

TypeDirect peer
Description

QuantiaMD was a physician-only social platform offering case collaboration, expert-led education, and peer discussions. It overlaps directly with Sermo's core verified-physician community and case consultation use cases as a focused HCP social platform.

TypeBroad incumbent
Description

Indegene provides commercialization services to life sciences companies, including medical affairs, marketing, and digital HCP engagement. It is comparable to Sermo in serving pharma clients with HCP-focused commercial engagement offerings, though broader and services-led.

TypeDirect peer
Description

Doximity is the largest professional medical network in the U.S. with over 2 million verified healthcare professional members. It is directly comparable to Sermo as a verified-HCP social networking platform serving physicians with networking, news, and pharma-sponsored content offerings.

TypeBroad incumbent
Description

Kyruus operates a provider search, scheduling, and data management platform for health systems and life sciences. While it is a broader healthcare data and engagement player, its physician data and provider engagement capabilities overlap with Sermo's HCP intelligence offering.

7Healthcasts
TypeDirect peer
Description

Healthcasts provides physician engagement and education through peer-to-peer video and digital content platforms. It is comparable to Sermo as a digital HCP engagement platform serving pharmaceutical clients with educational and promotional content distribution to verified physicians.

TypeEmerging player
Description

Figure 1 is a medical case-sharing platform used by physicians to share de-identified clinical images and discuss patient cases. It overlaps with Sermo's peer insights and case consultation feature set, though focused on visual case sharing rather than broader HCP community engagement.

TypeDirect peer
Description

Medscape (owned by WebMD) is a leading online destination for physicians and healthcare professionals offering clinical news, CME, and professional resources. It is directly comparable to Sermo's physician community and CME/education offerings, although Sermo adds a paid survey and engagement layer.

TypeEmerging player
Description

ZoomRx is a healthcare market research platform connecting pharma clients to physicians for surveys, advisory boards, and real-world insights. It is directly comparable to Sermo's paid survey and HCP market research offerings, though smaller and more focused on the U.S. market.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers4 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles5 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance4 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds7 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors7 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

SERMO

Healthcare Professional Network & Market Research Platformsermo.com

What SERMO does

Sermo is a physician-first social engagement platform that connects over 1 million triple-verified physicians and healthcare professionals across 150+ countries. Founded in 2005 and headquartered in New York, the company operates a closed, credentialed community where physicians participate in peer discussions, post challenging patient cases (2M+ peer insights shared annually), rate drugs in the world's largest physician drug ratings database (1.2M+ ratings), and complete paid market research surveys (with over $25M distributed to medical professionals last year). The platform extends to dedicated sub-communities for Advanced Practice Providers and Pharmacists, and produces the recurring Sermo Barometer HCP sentiment study series, now in its 45th edition.

The underlying technology combines social networking infrastructure, a proprietary triple-verification credential system for physician onboarding, the Drug Ratings™ branded database, mobile applications (app.sermo.com), and AI-powered analytics for personalized marketing and engagement insights. The platform's core technical differentiator is its scale: 1.5M+ verified members producing a continuous stream of structured and unstructured clinical signal that competitors cannot easily replicate.

Sermo's business model is a two-sided platform play. Physicians access the network free of charge and earn supplemental income through paid surveys, while pharmaceutical companies, medical device firms, and biotech firms pay for access through multiple revenue streams including RealTime surveys, sponsored content, Sermo Conversations, Sermo Promo, and Sermo Ratings. The October 2025 launch of Engagement Manager added on-demand self-serve advertising, and the 2021 acquisition of Australia's Minter Group expanded Asia-Pacific reach with 50,000+ additional healthcare professionals. The company is privately held, has received approximately $101M in disclosed funding across multiple rounds (most recently Series 4 from ABRY Partners in 2019), and is led by CEO Peter Kirk.

SERMO firmographics

Firmographics
Name
SERMO
Legal name
Sermo, Inc.
Website
https://sermo.com
Company type
Private
Founded year
2005
Operating status
Operating
Headcount range
501–1,000 employees
Ownership category
akta.pro rank

SERMO industry classification

Industry
Product category
Healthcare Professional Network & Market Research Platform
NAICS
Web Search Portals, Libraries, Archives, and Other Information Services (519)
SIC
Services-Health Services (8000)
akta.pro industry
PRIMARYHLAGACAG
Clinical Trial Monitoring Support (On-site/Remote)
SECONDARYHLAGAOAA
Clinical Operations & Monitoring FSP (CRA/CTM/Start-up)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Scientific Staffing & Functional Service Providers (FSP)

Keywords

  • Physician social network
  • Healthcare market research
  • HCP engagement platform
  • Physician drug ratings
  • Medical insights surveys

Where SERMO is headquartered

Location

Headquarters

HQ city
New York
HQ country
United States
HQ region
North America

Offices2 records

Markets served

SERMO business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure

Revenue model

  1. Pharmaceutical and Healthcare Industry Insights: Sermo provides pharmaceutical companies, medical device firms, and biotech companies with access to physician expertise through sponsored content, engagement sponsorship, RealTime surveys, Sermo Conversations, Sermo Promo, and Sermo Ratings. Organizations underwrite market research and engagement sponsorship opportunities on the platform.
  2. Market Research Surveys: Sermo facilitates paid medical surveys matching physician specialties, earning revenue from pharmaceutical clients who fund the surveys while physicians earn money for their participation. Medical professionals on Sermo earned over $25+ million in compensation last year.

Pricing tiers

ModelBillingPrice
FreemiumPay-as-you-goFree membership for physicians with earning opportunities through paid surveys

Go-to-market motion1 record

Distribution channels4 records

Marketing channels6 records

SERMO product offering

Product offering

Core offering

SERMO operates a verified physician-only social networking platform with over 1.5 million healthcare professionals across 150+ countries, providing peer-to-peer medical collaboration, paid medical surveys, and the world's largest physician drug ratings database (1.2M+ ratings). The company monetizes this network by offering pharmaceutical companies, medical device firms, and biotech clients access to physician insights, sponsored engagement, real-time market research surveys, and on-demand advertising via its Engagement Manager platform.

Product overview

Sermo is a physician-first social engagement platform and healthcare insights company offering a suite of interconnected products: the core Sermo Physician Social Network (a triple-verified social platform for 1M+ doctors), paired with the world's largest Drug Ratings Database (1.2M+ ratings) and a Paid Medical Survey program. The platform facilitates Peer Insights for case consultations (2M+ insights annually) and powers the Sermo Barometer, a recurring HCP sentiment study series now in its 45th edition that generates industry-wide healthcare insights. Additional offerings include the Engagement Manager (on-demand advertising access to verified HCPs), dedicated communities for APPs and Pharmacists, and a mobile application. The platform architecture combines social networking, market research, and real-world evidence generation for pharmaceutical and healthcare industry clients.

Differentiator

Problem solved

Functional benefit

Products and services

  • Sermo Physician Social Network The primary social networking platform for verified physicians and healthcare professionals, enabling peer-to-peer medical discussions, case consultations, anonymous interactions, and professional networking across 1.5M+ members in 150+ countries.
  • Drug Ratings Database The world's largest database of physician drug reviews containing over 1.2 million ratings, enabling physicians to share and access treatment reviews to improve patient care decisions globally.
  • Paid Medical Surveys Market research surveys matching physician specialties that enable medical professionals to earn supplemental income by sharing clinical expertise through paid participation in healthcare research studies funded by pharma clients.
  • Sermo Barometer A recurring HCP sentiment study series (45th edition) surveying thousands of global healthcare professionals on clinical trends, treatment patterns, industry challenges, and emerging therapies to generate actionable healthcare insights for pharmaceutical and industry clients.
  • Engagement Manager An on-demand advertising platform enabling pharmaceutical companies and healthcare advertisers to access and target SERMO's community of 1M+ triple-verified healthcare professionals with sponsored content and advertising.

Quantifiable outcome

  • 83% increase in global unique logins during COVID-19 pandemic
  • +2 more outcomes

Companies that use SERMO

Customer profile

Named customers4 records

Segments5 records

Ideal customer profiles2 records

SERMO technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

SERMO partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Minter GroupcoreStrategic or Co-development Partner · 15 June 2021Acquired Australia-based market research leader Minter Group on June 15, 2021. The acquisition expanded Sermo's research panel to include over 50,000 Asia-Pacific healthcare professionals, strengthening connections between the pharmaceutical industry and healthcare providers in emerging markets, particularly Asia-Pacific.

Scale indicators7 records

Recent moves6 records

Expansion highlights6 records

SERMO competitors and assessment

Company assessment

Broad incumbents

  • Veeva Systems: Veeva Systems provides cloud-based software for life sciences companies, including CRM, data, and commercial engagement tools used by pharma sales and marketing teams. It overlaps with Sermo's pharma customer base and HCP engagement use cases, but as a broader enterprise platform rather than a physician community.
  • Definitive Healthcare: Definitive Healthcare provides commercial intelligence and analytics on healthcare providers, including physicians, for life sciences and healthcare organizations. It is broadly comparable to Sermo as a healthcare commercial intelligence/data provider serving pharma clients.
  • Indegene: Indegene provides commercialization services to life sciences companies, including medical affairs, marketing, and digital HCP engagement. It is comparable to Sermo in serving pharma clients with HCP-focused commercial engagement offerings, though broader and services-led.
  • Kyruus: Kyruus operates a provider search, scheduling, and data management platform for health systems and life sciences. While it is a broader healthcare data and engagement player, its physician data and provider engagement capabilities overlap with Sermo's HCP intelligence offering.

Direct peers

  • QuantiaMD: QuantiaMD was a physician-only social platform offering case collaboration, expert-led education, and peer discussions. It overlaps directly with Sermo's core verified-physician community and case consultation use cases as a focused HCP social platform.
  • Doximity: Doximity is the largest professional medical network in the U.S. with over 2 million verified healthcare professional members. It is directly comparable to Sermo as a verified-HCP social networking platform serving physicians with networking, news, and pharma-sponsored content offerings.
  • Healthcasts: Healthcasts provides physician engagement and education through peer-to-peer video and digital content platforms. It is comparable to Sermo as a digital HCP engagement platform serving pharmaceutical clients with educational and promotional content distribution to verified physicians.
  • Medscape: Medscape (owned by WebMD) is a leading online destination for physicians and healthcare professionals offering clinical news, CME, and professional resources. It is directly comparable to Sermo's physician community and CME/education offerings, although Sermo adds a paid survey and engagement layer.

Emerging players

  • Figure 1: Figure 1 is a medical case-sharing platform used by physicians to share de-identified clinical images and discuss patient cases. It overlaps with Sermo's peer insights and case consultation feature set, though focused on visual case sharing rather than broader HCP community engagement.
  • ZoomRx: ZoomRx is a healthcare market research platform connecting pharma clients to physicians for surveys, advisory boards, and real-world insights. It is directly comparable to Sermo's paid survey and HCP market research offerings, though smaller and more focused on the U.S. market.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

SERMO social profiles

Digital presence

SERMO compliance and trust

Trust signal

Compliance4 records

SERMO financial estimates

Financial estimate

Revenue estimate

Valuation estimate

SERMO leadership team

Management profile

Number of profiles

Profiles5 records

SERMO subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

SERMO funding detail

Funding detail

Funding overview

Funding rounds7 records

Investors7 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

SERMO M&A and investment

M&A and investment

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about SERMO

What does SERMO do?

SERMO operates a verified physician-only social networking platform with over 1.5 million healthcare professionals across 150+ countries, providing peer-to-peer medical collaboration, paid medical surveys, and the world's largest physician drug ratings database (1.2M+ ratings). The company monetizes this network by offering pharmaceutical companies, medical device firms, and biotech clients access to physician insights, sponsored engagement, real-time market research surveys, and on-demand advertising via its Engagement Manager platform.

Is SERMO a public or private company?

SERMO is a private company. It is classified as private equity controlled and is currently operating.

When was SERMO founded?

SERMO was founded in 2005. It employs 501 to 1,000 people.

Where is SERMO based?

SERMO is headquartered in New York, United States, in the North America region.

How does SERMO make money?

Two revenue lines are on record. Pharmaceutical and Healthcare Industry Insights are the primary driver. The others are market Research Surveys.

Who are SERMO's main competitors?

Broad incumbents on record are Veeva Systems, Definitive Healthcare, Indegene and Kyruus. Direct peers are QuantiaMD, Doximity, Healthcasts and Medscape. Emerging players are Figure 1 and ZoomRx.

Does SERMO have an API?

No public API is recorded for SERMO.

What industry is SERMO in?

SERMO's product category is Healthcare Professional Network & Market Research Platform. Its primary akta.pro industry code is HLAGACAG, Clinical Trial Monitoring Support (On-site/Remote), with a secondary code of HLAGAOAA, Clinical Operations & Monitoring FSP (CRA/CTM/Start-up). Its NAICS code is 519 and its SIC code is 8000.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Insider IntelligenceDoctors and AI advocates clash over who should make clinical decisionsA JAMA article argues AI already outperforms physicians in diagnosing, prescribing, and managing chronic disease, predicting AI will surpass doctors as it improves. A Sermo survey found 99% of physicians want to retain final authority over AI-assisted recommendations, and 92% see AI's value in reducing administrative burden. AMA CEO John Whyte responded that medicine requires human judgment and intuition.AETOSWireSermo Survey Finds Opportunity to Educate General Care Physicians on PrEP to Increase Patient AdoptionSermo's survey of over 600 physicians found 46% of general care physicians lack sufficient PrEP knowledge, while 98% of infectious disease specialists feel confident. Cost was the top reason patients declined PrEP in the U.S., and 23% of general care physicians reported no resources for patients on parents' insurance.SermoPhysician case collaboration: A win-win for doctors and patients if done correctlyThe article promotes Sermo, a digital platform enabling peer-to-peer collaboration among physicians to improve diagnostic accuracy and patient outcomes in complex or rare medical cases. It highlights the platform's features, such as secure data sharing and access to a global network of over one million healthcare professionals, while contrasting them with the inefficiencies and privacy risks of traditional communication methods.SermoThe future of telemedicine: Top 20 trends shaping healthcare in 2025A survey of physicians within the Sermo community indicates that 75% already utilize telemedicine to improve workflow efficiency and address burnout, with 87% predicting continued growth in the sector. The article outlines twenty emerging trends for 2025, including AI-powered diagnostics, remote patient monitoring, and expanded reimbursement policies, which are reshaping healthcare delivery.AxiosAbry to sell physician social network SermoPrivate equity firm Abry has hired JPMorgan to sell its portfolio company Sermo, a physician social network platform, with sources indicating a target valuation between $600 million and $800 million. The sale process represents a potential monetization event for Abry's investment in the healthcare-focused digital platform. No buyer has been identified yet, and the deal remains contingent on market conditions and interested parties.CNBCSermo harnesses the power of collective physician expertise to advance health careSermo, a physician networking platform with over 1 million verified healthcare professional members across 150 countries, enables doctors to discuss patient cases, share treatment insights, and rate drugs in a secure, anonymized environment. The platform reports that 62% of its physician members have changed their perceptions of medications based on information accessed on the platform, and half have altered prescribing choices as a result, with approximately 7,000 patient cases crowdsourced annually in G7 countries alone. Sermo also operates a real-time insights platform and ongoing Barometer survey that supports pharmaceutical, biotechnology, and healthcare industry decision-makers, while exploring future AI integration to cross-index clinical trial data, patient records, and physician discussions.MorningstarSermo Barometer Finds 78% of US Physicians Think Health Insurance Companies Have Too Much Influence Over Patient Care Plans; 52% GloballyA Sermo Barometer survey of 529 global physicians found 78% of U.S. doctors believe health insurers have too much influence on care plans, down from 52% globally. Half of U.S. physicians said private equity investments have decreased care quality, and only 22% feel fully prepared for retirement.Business Wire BlogSermo Barometer Finds 78% of US Physicians Think Health Insurance Companies Have Too Much Influence Over Patient Care Plans; 52% GloballySermo's 36th Barometer survey of 529 global physicians found 78% of U.S. doctors believe health insurers have too much influence over care plans, versus 52% globally. Half of U.S. physicians said private equity investments have decreased care quality, while 54% of U.S. doctors cited retirement cost-of-living and savings as top concerns.Business Wire BlogSermo Barometer 35 Reveals HCPs Are Eager for GLP-1 Medications to Be Approved for New Uses, with Sleep Apnea Leading Over Chronic Heart Failure and MASHSermo's 35th Barometer survey of 1,150+ healthcare providers found HCPs most eager for GLP-1 approvals for sleep apnea, followed by chronic heart failure and MASH. The survey also highlighted concerns about patients self-adjusting doses and non-traditional settings prescribing these medications.